Galectin-1-mediated cell death is increased by CD30-induced signaling in anaplastic large cell lymphoma cells but not in Hodgkin lymphoma cells

Laboratory Investigation

Volumn 92, Issue 2, 2012, Pages 191-199

  Suzuki, Osamu ^a,b   Hirsch, Burkhard ^a   Abe, Masafumi ^b   Dürkop, Horst ^c   Stein, Harald ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c Department of Pathodiagnostik ^*  (Germany)

Author keywords

anaplastic large cell lymphoma; CD30; cell death; galectin 1; galectin 3; Hodgkin lymphoma; lectins

Indexed keywords

CD30 ANTIGEN; CELLULAR INHIBITOR OF APOPTOSIS 2; COMPLEMENTARY DNA; GALECTIN 1; GALECTIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG;

ARTICLE; CELL DEATH; CELL STIMULATION; CONTROLLED STUDY; DNA TRANSFECTION; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIGENS, CD30; APOPTOSIS; BASE SEQUENCE; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; FLOW CYTOMETRY; GALECTIN 1; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, LARGE-CELL, ANAPLASTIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84856431037     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2011.151     Document Type: Article

References (28)

1. Rabinovich GA, Rubinstein N, Toscano MA. Role of galectins in inflammatory and immunomodulatory processes. Biochim Biophys Acta 2002;1572:274-284. (Pubitemid 35246350)
2. Barondes SH. Soluble lectins: a new class of extracellular proteins. Science 1984;223:1259-1264. (Pubitemid 14163181)
3. Adams L, Scott GK, Weinberg CS. Biphasic modulation of cell growth by recombinant human galectin-1. Biochim Biophys Acta 1996;1312:137-144. (Pubitemid 26227444)
4. Perillo NL, Pace KE, Seilhamer JJ, et al. Apoptosis of T cells mediated by galectin-1. Nature 1995;378:736-739. (Pubitemid 126647279)
5. Rodig SJ, Ouyang J, Juszczynski P, et al. AP1-dependent galectin-1 expression delineates classical Hodgkin and anaplastic large cell lymphomas from other lymphoid malignancies with shared molecular features. Clin Cancer Res 2008;14:3338-3344.
6. Juszczynski P, Ouyang J, Monti S, et al. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc Natl Acad Sci USA 2007;104: 13134-13139. (Pubitemid 351737605)
7. Suzuki O, Nozawa Y, Abe M. Regulatory roles of altered N- and O-glycosylation of CD45 in galectin-1-induced cell death in human diffuse large B cell lymphoma. Int J Oncol 2005;26:1063-1068.
8. Hirsch B, Hummel M, Bentink S, et al. CD30-induced signaling is absent in Hodgkin0s cells but present in anaplastic large cell lymphoma cells. Am J Pathol 2008;172:510-520. (Pubitemid 351282036)
9. Konstantinov KN, Robbins BA, Liu FT. Galectin-3, a beta- galactosidebinding animal lectin, is a marker of anaplastic large-cell lymphoma. Am J Pathol 1996;148:25-30. (Pubitemid 26019639)
10. Hoyer KK, Pang M, Gui D, et al. An anti-apoptotic role for galectin-3 in diffuse large B-cell lymphomas. Am J Pathol 2004;164: 893-902. (Pubitemid 38235471)
11. Akahani S, Nangia-Makker P, Inohara H, et al. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 1997;57:5272-5276. (Pubitemid 27516362)
12. Fukumori T, Takenaka Y, Yoshii T, et al. CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis. Cancer Res 2003;63: 8302-8311. (Pubitemid 37549482)
13. Suzuki O, Abe M. Cell surface N-glycosylation and sialylation regulates galectin-3-induced apoptosis in human diffuse large B cell lymphoma. Oncol Rep 2008;19:743-748. (Pubitemid 351330444)
14. Hahn HP, Pang M, He J, et al. Galectin-1 induces nuclear translocation of endonuclease G in caspase- and cytochrome c-independent T cell death. Cell Death Diff 2004;11:1277-1286. (Pubitemid 39591773)
15. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-408. (Pubitemid 34164012)
16. Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin0s disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-858. (Pubitemid 15242469)
17. Dürkop H, Latza U, Hummel M, et al. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 1992;68: 421-427.
18. Hübinger G, Schneider C, Stöhr D, et al. CD30-induced up-regulation of the inhibitor of apoptosis genes cIAP1 and cIAP2 in anaplastic large cell lymphoma cells. Exp Hematol 2004;32:382-389. (Pubitemid 38410915)
19. Hubinger G, Muller E, Scheffrahn I, et al. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299. Oncogene 2001;20:590-598. (Pubitemid 32156183)
20. Jung W, Krueger S, Renner C, et al. Opposite effects of the CD30 ligand are not due to CD30 mutations: results from cDNA cloning and sequence comparison of the CD30 antigen from different sources. Mol Immunol 1994;31:1329-1334. (Pubitemid 24355145)
21. Gedrich RW, Gilfillan MC, Duckett CS, et al. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 1996;271:12852-12858. (Pubitemid 26176697)
22. Lee SY, Park CG, Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996;183:669-674.
23. Aizawa S, Nakano H, Ishida T, et al. Tumor necrosis factor receptorassociated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation. J Biol Chem 1997;272:2042-2045. (Pubitemid 27058475)
24. Dürkop H, Hirsch B, Hahn C, et al. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation. J Pathol 2003;200:229-239. (Pubitemid 36748032)
25. Duckett CS, Thompson CB. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF2 signaling and the control of cell survival. Genes Dev 1997;11:2810-2821. (Pubitemid 27481682)
26. Dürkop H, Hirsch B, Hahn C, et al. cIAP2 is highly expressed in Hodgkin-Reed-Sternberg cells and inhibits apoptosis by interfering with constitutively active caspase-3. J Mol Med 2006;84: 132-141. (Pubitemid 43201253)
27. Pace KE, Lee C, Stewart PL, et al. Restricted receptor segregation into membrane microdomains occurs on human T cells during apoptosis induced by galectin-1. J Immunol 1999;163:3801-3811. (Pubitemid 29450905)
28. Dumic J, Dabelic S, Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006;1760:616-635. (Pubitemid 44382499)